Literature DB >> 18626021

Conserved T cell receptor alpha-chain induces insulin autoantibodies.

Masakazu Kobayashi1, Jean Jasinski, Edwin Liu, Marcella Li, Dongmei Miao, Li Zhang, Liping Yu, Maki Nakayama, George S Eisenbarth.   

Abstract

A fundamental question is what are the molecular determinants that lead to spontaneous preferential targeting of specific autoantigens in autoimmune diseases, such as the insulin B:9-23 peptide sequence in type 1 diabetes. Anti-insulin B:9-23 T cell clones isolated from prediabetic NOD islets have a conserved Valpha-segment/Jalpha-segment, but no conservation of the alpha-chain N region and no conservation of the Vbeta-chain. Here, we show that the conserved T cell receptor alpha-chain generates insulin autoantibodies when transgenically or retrogenically introduced into mice without its corresponding Vbeta. We suggest that a major part of the mystery as to why islet autoimmunity develops relates to recognition of a primary insulin peptide by a conserved alpha chain T cell receptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626021      PMCID: PMC2464615          DOI: 10.1073/pnas.0801648105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains.

Authors:  N Abiru; L Yu; D Miao; A K Maniatis; E Liu; H Moriyama; G S Eisenbarth
Journal:  J Autoimmun       Date:  2001-08       Impact factor: 7.094

2.  Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice.

Authors:  N Abiru; A K Maniatis; L Yu; D Miao; H Moriyama; D Wegmann; G S Eisenbarth
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

Review 3.  A comprehensive guide to antibody and T-cell responses in type 1 diabetes.

Authors:  S M Lieberman; T P DiLorenzo
Journal:  Tissue Antigens       Date:  2003-11

4.  Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.

Authors:  Maki Nakayama; Joshua N Beilke; Jean M Jasinski; Masakazu Kobayashi; Dongmei Miao; Marcella Li; Marilyne G Coulombe; Edwin Liu; John F Elliott; Ronald G Gill; George S Eisenbarth
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

5.  Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes.

Authors:  L Yu; D T Robles; N Abiru; P Kaur; M Rewers; K Kelemen; G S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  Induction of insulin autoantibodies and protection from diabetes with subcutaneous insulin B:9-23 peptide without adjuvant.

Authors:  Edwin Liu; Norio Abiru; Hiroaki Moriyama; Dongmei Miao; George S Eisenbarth
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

7.  CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

Authors:  Rinee Mukherjee; Pratibha Chaturvedi; Hui-Yu Qin; Bhagirath Singh
Journal:  J Autoimmun       Date:  2003-11       Impact factor: 7.094

8.  Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.

Authors:  Hiroaki Moriyama; Norio Abiru; Johanna Paronen; Kamila Sikora; Edwin Liu; Dongmei Miao; Devasenan Devendra; Joshua Beilke; Roberto Gianani; Ron G Gill; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

9.  Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice.

Authors:  Karine Thébault-Baumont; Danielle Dubois-Laforgue; Patricia Krief; Jean-Paul Briand; Philippe Halbout; Karine Vallon-Geoffroy; Joëlle Morin; Véronique Laloux; Agnès Lehuen; Jean-Claude Carel; Jacques Jami; Sylviane Muller; Christian Boitard
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

10.  Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.

Authors:  Elmar Jaeckel; Ludger Klein; Natalia Martin-Orozco; Harald von Boehmer
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307

View more
  20 in total

Review 1.  Treg vaccination with a strong-agonistic insulin mimetope.

Authors:  Benno Weigmann; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

Review 2.  Genetics, pathogenesis and clinical interventions in type 1 diabetes.

Authors:  Jeffrey A Bluestone; Kevan Herold; George Eisenbarth
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

3.  Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.

Authors:  Frances Crawford; Brian Stadinski; Niyun Jin; Aaron Michels; Maki Nakayama; Philip Pratt; Philippa Marrack; George Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 4.  The anti-insulin trimolecular complex in type 1 diabetes.

Authors:  Aaron W Michels; Maki Nakayama
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-08       Impact factor: 3.243

Review 5.  T-cell receptor retrogenic mice: a rapid, flexible alternative to T-cell receptor transgenic mice.

Authors:  Matthew L Bettini; Maria Bettini; Dario A A Vignali
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

6.  Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.

Authors:  Li Zhang; Frances Crawford; Liping Yu; Aaron Michels; Maki Nakayama; Howard W Davidson; John W Kappler; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

7.  Gamma delta T cell receptors confer autonomous responsiveness to the insulin-peptide B:9-23.

Authors:  Li Zhang; Niyun Jin; Maki Nakayama; Rebecca L O'Brien; George S Eisenbarth; Willi K Born
Journal:  J Autoimmun       Date:  2010-01-18       Impact factor: 7.094

Review 8.  Targeting the trimolecular complex.

Authors:  Aaron W Michels
Journal:  Clin Immunol       Date:  2013-03-05       Impact factor: 3.969

9.  Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.

Authors:  George S Eisenbarth
Journal:  Diabetes       Date:  2010-04       Impact factor: 9.461

10.  Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains.

Authors:  Li Zhang; Jean M Jasinski; Masakazu Kobayashi; Bennett Davenport; Kelly Johnson; Howard Davidson; Maki Nakayama; Kathryn Haskins; George S Eisenbarth
Journal:  J Autoimmun       Date:  2009-03-16       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.